FemtoMarch Medical

Shenzhen FemtoMarch Medical Technology Co., Ltd. focuses on the clinical translation of femtosecond lasers in the field of ophthalmic surgery, with its main product being an ophthalmic femtosecond laser treatment system. Based on nearly a decade of research in "optics-laser-ophthalmic laser," in November 2022, femtosecond laser scientists from the Chinese Academy of Sciences (CAS) joined forces with senior experts from the medical industry to establish Shenzhen FemtoMarch Medical Technology Co., Ltd. The company is dedicated to the forward-looking development of core femtosecond laser components and complete machine systems, deeply cultivating a fully autonomous ophthalmic femtosecond laser treatment system for refractive and corneal surgeries. The company has successfully overcome four major technical challenges: high-precision large-field three-dimensional optical scanning systems, medical-grade femtosecond lasers, real-time closed-loop monitoring and control technology, and customized refractive correction algorithms.